|
HS Code |
532020 |
| Product Name | Tert-Butyl 5-Bromo-1H-Indazole-1-Carboxylate |
| Cas Number | 1393566-69-0 |
| Molecular Formula | C12H13BrN2O2 |
| Molecular Weight | 297.15 g/mol |
| Appearance | White to off-white solid |
| Purity | Typically ≥ 95% |
| Solubility | Soluble in organic solvents such as DMSO and DMF |
| Storage Temperature | 2-8°C (Refrigerated) |
| Smiles | CC(C)(C)OC(=O)n1nc2ccc(Br)cc2c1 |
| Inchi | InChI=1S/C12H13BrN2O2/c1-12(2,3)17-11(16)15-10-5-4-7-8(13)6-9(7)14-10/h4-6H,1-3H3,(H,15,16) |
As an accredited Tert-Butyl 5-Bromo-1H-Indazole-1-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive Tert-Butyl 5-Bromo-1H-Indazole-1-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Scientific progress often depends on finding the right tools for the job, and Tert-Butyl 5-Bromo-1H-Indazole-1-Carboxylate keeps showing up at the bench when ideas need to move from sketch to synthesis. Over the last decade, the indazole scaffold has moved high on the list for researchers diving into medicinal chemistry, especially in programs targeting kinases, inflammation modulators, or new routes in material science. The bromo group at the five position and the strategically camouflaged carboxyl moiety open doors to powerful cross-coupling and derivatization chemistry that simply isn’t possible with unadorned starting points.
Working with chemical intermediates that combine selectivity and flexibility becomes important when stakes are high. The tert-butyl ester holds up robustly in a variety of conditions, outlasting other protecting groups during synthetic routes known to test every functional group’s mettle. Junior chemists often share stories about how acid-labile esters complicate long sequences, collapsing right when a project picks up pace. Tert-butyl, by contrast, keeps the carboxylate safe until deprotection is desired, and delivers cleanly when needed, usually with mild acid. This keeps timelines on track.
The 5-bromo substituent sits at a synthetically useful position, perfectly poised for Suzuki, Sonogashira, and Buchwald-Hartwig couplings. Aromatic bromides couple with wide-ranging boronic acids or amines, making this molecule a versatile stepping stone in libraries meant for SAR (structure–activity relationship) campaigns. For those mapping out kinase inhibitors or new probe molecules, filling a plate with analogs gets a lot easier by starting with this sort of scaffold. It’s also worth noting that the 1H-indazole ring system itself serves as a privileged structure, decorating the backbones of several recently approved drugs.
Drug discovery rarely rewards guesswork. Most breakthroughs follow careful exploration of leads with hardware and software running overtime. For a while, I worked in a project where the smallest change in a substituent could mean the difference between a potent hit and a compound that never saw daylight. We learned fast how valuable a brominated intermediate can be when setting up an array of molecular tweaks. With the indazole backbone, you avoid the dead-ends that often crop up with less tractable aromatic cores or those hesitant to undergo activation or further derivatization.
The tert-butyl group’s reliability in multi-step syntheses earns respect from anyone chasing down long and winding routes. Whether working late in graduate school or later doing contract synthesis, I found confidence in reactions less prone to frustrating side-products. This translates into fewer wasted runs, which matters beyond the bottom line—less time in the lab frees up creative thinking and faster answers.
The structure’s value stretches past classic small-molecule drugs. In the hands of a skillful team, Tert-Butyl 5-Bromo-1H-Indazole-1-Carboxylate fits into programs mapping out fluorescent dyes, biochemical probes, or synthetic receptor ligands. The ability to dial in solubility, bioavailability, and affinity by exchanging the bromo group for all manner of tectonic changes in side chains proves a major advantage. Specialty chemicals based on indazoles pop up in agricultural chemistry and advanced materials development, areas where fine control over electronic and steric features pays off.
For academics and commercial R&D groups alike, having this intermediate available means spending less time troubleshooting stubborn functionalization steps and more time putting hypothesis to test. The availability of tert-butyl protected carboxylates ensures shelf-life and stability, especially when other esters or acids would break down under atmospheric moisture or impure solvents. Knowing from experience how shelf-stable compounds keep mishaps in check means real dollars saved and a smoother workflow in the lab. Waste isn’t just a budget line; it’s extra hours at the bench that could be spent on actual discovery.
While simple indazoles make suitable starting points for some syntheses, they don’t allow the same breadth of transformation. Other 5-substituted variants—like 5-chloro or 5-iodo indazoles—bring something to the table, but the bromide forms a sweet spot. It’s reactive enough for efficient palladium-catalyzed coupling, but it isn’t so labile as to cause decomposition or side reactions under normal handling. The chemistry of aryl bromides consistently outpaces their chloride cousins in cross-coupling yields and reaction rates, and cost considerations often narrow options when scale creeps up.
The protection on the carboxyl group marks another fresh advantage. Methyl or ethyl esters, though common, regularly face unhelpful reactivity in both acid and base. Tert-butyl resists hydrolysis during routine workups, and deprotection comes off clean with minimal overreaction—an outcome no chemist wants to take chances on near the end of a sequence.
Hard-won lessons from a few failed late-stage modifications teach you fast: It’s not just about getting a reaction to run, but about getting it to finish cleanly in the presence of every other group you’ve painstakingly installed. The right protecting group often makes or breaks the difference between a publishable synthesis and a smudge on the lab notebook.
Consistency matters, especially when you’re preparing sensitive bioactives or running scale-ups. Laboratories demand high purity and batch reliability. Tert-Butyl 5-Bromo-1H-Indazole-1-Carboxylate reliably arrives as a solid, handled and weighed without special atmosphere—very little hygroscopicity, noticeably robust. In-house and third-party analyses typically call for purity above 97% by HPLC or NMR, with tightly controlled residual solvents. This reliability stands out when compared with more variable sources or intermediates that struggle with shelf instability or batch-to-batch differences.
Modern labs typically favor input chemicals with traceable quality documentation and full spectral data, covering everything from proton and carbon NMR to LC-MS. This is true for any regulated synthesis, whether producing a library for early-stage SAR or working under Good Manufacturing Practice for an advanced project. I remember the ease of pushing through my workflow when key intermediates showed up with complete paperwork. Fewer unknowns mean less troubleshooting—something every project leader eventually comes to value.
Researchers sometimes underestimate the headache that comes from compounds that shift, deliquesce, or degrade faster than you can set up a reaction. The tert-butyl ester’s resilience in Tert-Butyl 5-Bromo-1H-Indazole-1-Carboxylate often means less special handling. Store it in a cool, dry place and even after months, a fresh sample will look and perform like the day you received it. No surprise peaks show up under spectral analysis, and solubility in common organic solvents lets reactions get started without fancy workarounds.
There’s a comfort to using intermediates that have survived the rough handling of real research labs. Spilled bottles, poorly sealed vials, a few weeks out of cold storage—these things should never mean a product’s wasted. The tert-butyl indazole holds up so well that teams working round the clock can grab it off the shelf without pausing to ask about freshness. That kind of reliability carries a quiet weight in demanding environments.
The journey from bench discovery to practical application in pharmaceuticals or specialty chemicals asks for transparency, especially around chemical safety and environmental practices. Labs value suppliers and intermediates backed by clear data about purity, trace solvent levels, and origin—but also about safe handling and expected breakdown products. Tert-Butyl 5-Bromo-1H-Indazole-1-Carboxylate, with its moderate toxicity profile and manageable vapor pressure, fits into the routines many labs already follow for aromatic organobromides. Experienced hands always recommend protective equipment and well-ventilated benches, but this chemical doesn’t bring surprises outside those already mapped by standard protocols.
I recall times a trusted supplier’s batch came with a full panel of data—NMR, LC-MS, clear guidance for incompatible materials, and outlined disposal suggestions in line with current best practices. You never feel quite as exposed to risk. Many labs have built-in containment and neutralization steps for bromo-aromatics, so the work proceeds with confidence and compliance in mind.
Chemistry keeps evolving. Indazoles once lived mostly in specialty synthesis, but the past few years record surging interest fueled by big leaps in kinase research, immunomodulating therapies, and advanced sensor tech. Tert-Butyl 5-Bromo-1H-Indazole-1-Carboxylate sits in the center of this uptick. Academic journals show a steady spike in new compounds traced back to its bromo position, while patents in medicinal chemistry often circle around derivatives created from this same molecule.
Fragment-based drug discovery now benefits from indazole cores, especially ones amenable to systematic diversification. As screening libraries continue to grow, researchers zero in on scaffolds that let them test dozens of chemical environments with minimal rebuilding. Anyone who’s pipetted into 384-well plates day after day learns quickly which molecules make high-throughput screening a pleasure and which ones gum up the process. Brominated indazole esters stand out for their reliable functionalization profiles and predictability in scale-up—two qualities less common in unprotected or multiply-substituted indazoles.
Synthetic chemistry never exists in isolation. Patterns seen in drug development often spill into specialty material production, and the bromo-indazole backbone proves no different. Teams engaged in creating new light-absorbing materials or sensor arrays rely on the combination of electronic properties and straightforward chemical modification this molecule delivers.
In agricultural research, substituted indazoles crop up in lead optimization for pest control agents and growth regulators. The tert-butyl ester paves the way for variable modifications, letting researchers tweak absorption and degradation in field trials without rebuilding base scaffolds from scratch. In all these fields, the right intermediate can shave months or years off a timeline, multiplying the impact of a single chemical with the right balance of stability and flexibility.
The true test of any chemical intermediate comes from repeat experience. Projects sometimes succeed not because of a single breakthrough, but because the basic building blocks show up every time, without fuss. Looking back, many of my lab mates found themselves stuck in rerun loops, unraveling side reactions or chasing clean-up on overreactive intermediates. Reliable tert-butyl-protected indazoles always meant fewer headaches and steadier progress.
You start to appreciate not only versatility and reactivity but also the quieter benefits—ease of handling, long-term storage, and the comfort of knowing no last-minute failures will throw timelines off track. These qualities have a way of showing up most in environments where every week counts and every gram of product finds a use in accelerated discovery.
No product exists in a vacuum; even high-performing intermediates present questions for the next generation of chemists. Considerations around sustainability, green chemistry, and hazardous waste now shadow every procurement and experimental decision. Organobromides, for all their practical advantages, carry baggage in the waste stream. Labs and manufacturers continue to search for partners with better recycling and reclamation practices, and for suppliers investing in cleaner, safer production protocols.
Learning to work more responsibly with valuable chemical assets has reshaped our field over recent years. Many labs now engage in solvent minimization and improved scrubbing of bromo-containing side products. Upstream traceability, supported by real documentation and transparent sourcing, provides an extra layer of assurance for regulatory scrutiny. These shifts do not just support compliance; they carve new paths toward broader acceptance of advanced intermediates like Tert-Butyl 5-Bromo-1H-Indazole-1-Carboxylate in industries outside medicinal chemistry.
Best practices grow from both institutional wisdom and the mistakes made late at night chasing elusive yields. In project reviews, the same advice resurfaces: source from established, reputable suppliers, check every COA (Certificate of Analysis), and maintain rigorous batch-testing protocols. Labs that take the extra step of confirming identity by NMR or LC-MS before diving into multi-gram synthesis sidestep considerable setbacks.
Training junior researchers to appreciate why certain protecting groups were selected—why tert-butyl, not methyl—fosters better decision-making. Courses and mentorship devoted to reaction troubleshooting and long-term sample storage cut down on learning by failure, resulting in teams who know how to spot and avoid the pitfalls unique to aromatic ester chemistry.
For organizations with an eye toward long-term capability, rotating stock and running stability tests on new lot numbers catches problems before they cost a week of missed milestones. Cross-team sharing of best handling tips—reagent solubility quirks, deprotection regimen subtleties, compatible coupling partners—brings real value to high-throughput workflows.
Chemistry advances one intermediate at a time. Tert-Butyl 5-Bromo-1H-Indazole-1-Carboxylate has carved a niche for itself in labs tackling hard problems from multiple angles—drug design, sensor development, agricultural solutions, and more. Decades of practical use have shown the worth of intermediates that balance reactivity, stability, and reliability.
By making careful, informed choices about which building blocks to place at the center of synthetic schemes, research teams gain more than just a successful reaction. They capture efficiencies, lower waste, and build protocols that help entire organizations do better science. As supply chains tighten and best practices in sustainability and transparency rise to the forefront, the value of robust, versatile intermediates will only grow.
Whether planning the next round of kinase inhibitors, crafting diagnostic probes, or mapping out the path for new agrochemicals, Tert-Butyl 5-Bromo-1H-Indazole-1-Carboxylate will continue to serve as a workhorse. For those who know its strengths and its quirks, this molecule stands as a testament to how thoughtful design and field-tested performance steer progress in both chemistry and the industries it powers.